GoodRx Stock Analysis

GDRX
 Stock
  

USD 6.08  0.27  4.25%   

The current slide in stock price may raise some interest from investors. The stock closed today at a share price of 6.08 on 3,158,717 in trading volume. The company executives have failed to build on market volatilities in July. However, diversifying your overall positions with GoodRx Holdings may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.74. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the GoodRx Holdings partners.
Please check Risk vs Return Analysis.
  
The GoodRx Holdings stock analysis report makes it easy to digest most publicly released information about GoodRx Holdings and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. GoodRx Stock analysis module also helps to analyze the GoodRx Holdings price relationship with some important fundamental indicators such as market cap and management efficiency.

GoodRx Stock Analysis Notes

About 77.0% of the company shares are owned by institutional investors. The book value of GoodRx Holdings was currently reported as 2.12. The company has Price/Earnings To Growth (PEG) ratio of 1.1. GoodRx Holdings recorded a loss per share of 0.7. The entity had not issued any dividends in recent years. GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company was incorporated in 2015 and is headquartered in Santa Monica, California. GoodRx Holdings operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 756 people. To learn more about GoodRx Holdings call the company at 855 268 2822 or check out https://www.goodrx.com.

GoodRx Holdings Quarterly Cost of Revenue

18.04 Million

GoodRx Holdings Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. GoodRx Holdings' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding GoodRx Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
GoodRx Holdings generated a negative expected return over the last 90 days
GoodRx Holdings has high historical volatility and very poor performance
GoodRx Holdings has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 788.32 M. Net Loss for the year was (14.63 M) with profit before overhead, payroll, taxes, and interest of 698.71 M.
Over 77.0% of the company shares are owned by institutional investors
Latest headline from www.fiercehealthcare.com: With Amazon alum at the helm, Alto Pharmacy charts next chapter - FierceHealthcare

GoodRx Holdings Upcoming and Recent Events

Earnings reports are used by GoodRx Holdings to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GoodRx Holdings previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report10th of March 2022
Next Financial Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End10th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

GoodRx Largest EPS Surprises

Earnings surprises can significantly impact GoodRx Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-02-28
2021-12-310.10.09-0.0110 
2021-03-11
2020-12-310.070.080.0114 
2020-11-12
2020-09-300.080.090.0112 
View All Earnings Estimates

GoodRx Holdings SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. GoodRx Holdings prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that GoodRx Holdings investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial GoodRx Holdings specific information freely available to individual and institutional investors to make a timely investment decision.
8th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
28th of June 2022
Financial Statements and Exhibits
View
17th of June 2022
Submission of Matters to a Vote of Security Holders
View
9th of May 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
View
25th of April 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
15th of April 2022
Financial Statements and Exhibits. Completion of Acquisition or Disposition of Assets
View
11th of April 2022
Unclassified Corporate Event
View
7th of March 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Entry into a Material Definitive Agreement
View

GoodRx Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 2.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GoodRx Holdings's market, we take the total number of its shares issued and multiply it by GoodRx Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

GoodRx Profitablity

GoodRx Holdings' profitability indicators refer to fundamental financial ratios that showcase GoodRx Holdings' ability to generate income relative to its revenue or operating costs. If, let's say, GoodRx Holdings is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, GoodRx Holdings' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of GoodRx Holdings' profitability requires more research than a typical breakdown of GoodRx Holdings' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.86) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 4.84 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.05.
Last ReportedProjected for 2022
Return on Average Assets(0.016) (0.0173) 
Return on Average Equity(0.031) (0.0318) 
Return on Invested Capital 0.016  0.0173 
Return on Sales 0.018  0.0194 

Management Efficiency

The entity has return on total asset (ROA) of 1.56 % which means that it generated profit of $1.56 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (1.91) %, meaning that it created substantial loss on money invested by shareholders. GoodRx Holdings management efficiency ratios could be used to measure how well goodrx holdings manages its routine affairs as well as how well it operates its assets and liabilities. GoodRx Holdings Return on Invested Capital is fairly stable at the moment as compared to the past year. GoodRx Holdings reported Return on Invested Capital of 0.016 in 2021. Return on Sales is likely to rise to 0.0194 in 2022, whereas Return on Average Assets are likely to drop (0.0173)  in 2022. GoodRx Holdings Tax Assets are fairly stable at the moment as compared to the past year. GoodRx Holdings reported Tax Assets of 15.08 Million in 2021. Asset Turnover is likely to rise to 0.55 in 2022, whereas Total Assets are likely to drop slightly above 1.4 B in 2022.
Last ReportedProjected for 2022
Book Value per Share 2.03  2.19 
Enterprise Value over EBIT 952.00  760.42 
Enterprise Value over EBITDA 250.95  270.77 
Price to Book Value 15.67  16.21 
Tangible Assets Book Value per Share 2.79  2.66 
Enterprise Value12.8 B12.7 B
Tangible Asset Value1.1 B963.5 M

Technical Drivers

As of the 19th of August, GoodRx Holdings retains the market risk adjusted performance of (0.12), and Risk Adjusted Performance of (0.06). GoodRx Holdings technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for GoodRx Holdings, which can be compared to its competitors. Please check out GoodRx Holdings standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if GoodRx Holdings is priced fairly, providing market reflects its last-minute price of 6.08 per share. Given that GoodRx Holdings has jensen alpha of (0.45), we strongly advise you to confirm GoodRx Holdings's regular market performance to make sure the company can sustain itself at a future point.

GoodRx Holdings Price Movement Analysis

The output start index for this execution was fourty-one with a total number of output elements of twenty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GoodRx Holdings middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GoodRx Holdings. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
.

GoodRx Holdings Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GoodRx Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on GoodRx Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GoodRx Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Voermann Karsten over a month ago via Macroaxis 
Sale by Voermann Karsten of 2200 shares of GoodRx Holdings
Beri Raj over a month ago via Macroaxis 
Acquisition by Beri Raj of 1788419 shares of GoodRx Holdings subject to Rule 16b-3
Bradley Julie Mb over two months ago via Macroaxis 
Acquisition by Bradley Julie Mb of 27440 shares of GoodRx Holdings subject to Rule 16b-3
Hirsch Douglas Joseph over two months ago via Macroaxis 
Conversion by Hirsch Douglas Joseph of 129375 shares of GoodRx Holdings
Nabiey Romin over three months ago via Macroaxis 
GoodRx Holdings exotic insider transaction detected
Idea Men Llc over three months ago via Macroaxis 
Conversion by Idea Men Llc of 116673 shares of GoodRx Holdings
Slutsky Andrew over three months ago via Macroaxis 
Exercise or conversion by Slutsky Andrew of 62500 shares of GoodRx Holdings subject to Rule 16b-3
Slutsky Andrew over three months ago via Macroaxis 
Exercise or conversion by Slutsky Andrew of 91667 shares of GoodRx Holdings subject to Rule 16b-3
Hirsch Douglas Joseph over three months ago via Macroaxis 
Conversion by Hirsch Douglas Joseph of 134716 shares of GoodRx Holdings
Idea Men Llc over six months ago via Macroaxis 
Bona fide gift to Idea Men Llc of 1800000 shares of GoodRx Holdings subject to Section 16
Azad Babak over six months ago via Macroaxis 
Exercise or conversion by Azad Babak of 12500 shares of GoodRx Holdings subject to Rule 16b-3
Idea Men Llc over six months ago via Macroaxis 
Conversion by Idea Men Llc of 2600 shares of GoodRx Holdings

GoodRx Holdings Predictive Daily Indicators

GoodRx Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GoodRx Holdings stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

GoodRx Holdings Forecast Models

GoodRx Holdings time-series forecasting models is one of many GoodRx Holdings' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GoodRx Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About GoodRx Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how GoodRx Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GoodRx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as GoodRx Holdings. By using and applying GoodRx Stock analysis, traders can create a robust methodology for identifying GoodRx entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin 0.07  0.07 
Gross Margin 0.94  0.90 
Profit Margin(0.034) (0.0367) 

Current GoodRx Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. GoodRx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. GoodRx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
45.33Buy12Odds
GoodRx Holdings current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most GoodRx analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand GoodRx stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of GoodRx Holdings, talking to its executives and customers, or listening to GoodRx conference calls.
GoodRx Analyst Advice Details

GoodRx Stock Analysis Indicators

GoodRx Holdings stock analysis indicators help investors evaluate how GoodRx Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading GoodRx Holdings shares will generate the highest return on investment. By understating and applying GoodRx Holdings stock analysis, traders can identify GoodRx Holdings position entry and exit signals to maximize returns.
Quick Ratio16.42
Fifty Two Week Low5.61
Revenue Growth26.70%
Shares Short Prior Month18.01M
Average Daily Volume Last 10 Day8.3M
Average Daily Volume In Three Month2.81M
Earnings Growth663.50%
Shares Percent Shares Out4.71%
Earnings Quarterly Growth637.00%
Gross Margins93.84%
Short Percent Of Float30.72%
Forward Price Earnings18.02
Float Shares70.92M
Fifty Two Week High48.05
Enterprise Value To Ebitda34.95
Fifty Day Average6.65
Two Hundred Day Average20.54
Enterprise Value To Revenue2.95
Please check Risk vs Return Analysis. Note that the GoodRx Holdings information on this page should be used as a complementary analysis to other GoodRx Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for GoodRx Stock analysis

When running GoodRx Holdings price analysis, check to measure GoodRx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GoodRx Holdings is operating at the current time. Most of GoodRx Holdings' value examination focuses on studying past and present price action to predict the probability of GoodRx Holdings' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move GoodRx Holdings' price. Additionally, you may evaluate how the addition of GoodRx Holdings to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Is GoodRx Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoodRx Holdings. If investors know GoodRx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoodRx Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
6.64
Market Capitalization
2.6 B
Quarterly Revenue Growth YOY
0.086
Return On Assets
0.0136
Return On Equity
-0.0574
The market value of GoodRx Holdings is measured differently than its book value, which is the value of GoodRx that is recorded on the company's balance sheet. Investors also form their own opinion of GoodRx Holdings' value that differs from its market value or its book value, called intrinsic value, which is GoodRx Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoodRx Holdings' market value can be influenced by many factors that don't directly affect GoodRx Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GoodRx Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine GoodRx Holdings value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoodRx Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.